Clinical Trials Browser

Recruiting × Autoimmune Diseases of the Nervous System × 90 days × Clear all

Multiple Sclerosis, Myasthenia Gravis, Recurrence, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07526493 2026-05-12

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Phase 1 Recruiting

6 enrolled

Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT04698421 2026-03-19

EXPLAINEUR

Recruiting

1,000 enrolled

Nervous System Diseases, Autoimmune Diseases of the Nervous System, Paraneoplastic Cerebellar Degeneration

Clinical Trials

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

EXPLAINEUR